Management of liver diseases during the pandemic of coronavirus disease-19
Ju-Yeon Cho, Soon Sun Kim, Young-Sun Lee, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim,
Clin Mol Hepatol. 2020;26(3):243-250.   Published online 2020 Jun 23     DOI: https://doi.org/10.3350/cmh.2020.0111
Citations to this article as recorded by Crossref logo
Autoimmune liver disease represented as primary biliary cholangitis after SARS-CoV-2 infection: A need for population-based cohort study
Soon Kyu Lee, Jung Hyun Kwon, Nara Yoon, Soon Woo Nam, Pil Soo Sung
Clinical and Molecular Hepatology.2022; 28(4): 926.     CrossRef
Forms of cholangitis to be considered after SARS-CoV-2 infection
Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim
Clinical and Molecular Hepatology.2022; 28(4): 929.     CrossRef
Management of Patients with Chronic Liver Disease: The Era of the COVID-19 Pandemic
Yu Rim Lee
The Korean Journal of Gastroenterology.2021; 77(4): 156.     CrossRef
Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline
Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim
Clinical and Molecular Hepatology.2021; 27(4): 515.     CrossRef
Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study
Gianluca Ianiro, Stefano Bibbò, Luca Masucci, Gianluca Quaranta, Serena Porcari, Carlo Romano Settanni, Loris Riccardo Lopetuso, Massimo Fantoni, Maurizio Sanguinetti, Antonio Gasbarrini, Giovanni Cammarota
Digestive and Liver Disease.2020; 52(12): 1390.     CrossRef